Written by James Kingsland on February 14, 2022 — Fact checked by Anna Guildford, Ph.D. A small study suggests that treating patients who have moderate or severe COVID-19 with ceftazidime or cefepime, plus the steroid dexamethasone, is as effective as standard...
By Katharine Lang Evidence is growing that a common antidepressant may reduce the severity of symptoms and mortality following SARS-CoV-2 infection.In an observational study, patients taking selective serotonin reuptake inhibitors (SSRIs) were 8% less likely to die...
by Deep Shukla Acute respiratory distress syndrome (ARDS) is a potentially fatal condition involving lung damage, and experts often associate it with severe COVID-19.There is a link between high mortality rates and COVID-19-induced ARDS, which is why there is an...